Riskpilot← Back to searchSign inGet full accessSMERTEKLINIKKEN AS
ASActiveOrg 926203452Kirkeveien 64A, 0364 OsloMedical specialists activities · NACE 8622Est. 20202 employees
Revenue 2025
NOK 2,3M
-31% vs 2024
EBITDA margin
0.1%
-97% vs 2024
Equity ratio
86.0%
Financial strength
Net profit 2025
NOK 3K
-96% vs 2024
| Revenue | NOK 2,3M | -31% |
| EBITDA | NOK 3K | -97% |
| Net profit | NOK 3K | -96% |
| Total assets | NOK 594K | -24% |
| Equity | NOK 511K | +1% |
| Employees | 2 | — |
Legal name
SMERTEKLINIKKEN AS
Org number
926203452
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
21. desember 2020
Share capital
NOK 425 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Mdisinsk service, handel, investering i andre selskaper og hva herved står i forbindelse.
Address
Kirkeveien 64A, 0364 Oslo
Phone
+4723202800
Email
post@smerteklinikkenoslo.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 793 | 3 253 | 3 256 | 3 306 | 2 288 |
| Staff expenses | −1 046 | −1 208 | −1 276 | −1 132 | −534 |
| EBITDA | −57 | 152 | −22 | 86 | 3 |
| Depreciation & amort. | −25 | −25 | −0 | −0 | −0 |
| EBIT | −82 | 127 | −22 | 86 | 3 |
| Net financials | −3 | −1 | −3 | 5 | 2 |
| Profit before tax | −85 | 126 | −25 | 91 | 5 |
| Tax | −0 | 16 | −0 | 8 | 1 |
| Net profit | −85 | 110 | −25 | 83 | 3 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 526 | 740 | 681 | 779 | 594 |
| Equity | −55 | 450 | 425 | 508 | 511 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 581 | 290 | 256 | 271 | 83 |
| Total debt | 581 | 290 | 256 | 271 | 83 |
EBITDA margin
0.1%
This company
15.8%
Market median
-99% vs market
20212025
Equity ratio
86.0%
This company
38.2%
Market median
+125% vs market
20212025
Return on equity
0.6%
This company
18.4%
Market median
-97% vs market
20212025
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20212025
Asset turnover
3.85×
This company
1.12×
Market median
+244% vs market
20212025
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IH Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Chairman | 2022 | |
| Former (2) | ||
| Board of Directors | 2022 – 2023 | |
| Chairman | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SMERTEKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Irene-Rama Halden Vinje | Chief Executive Officer | 0 companies |
| Abdullah Mohammud | Chairman | 0 companies |
| Kjell Aage Moe Torp-Joakimsen | Board of Directors | 0 companies |
| Dag Anthony Kaare | Chairman | 0 companies |
| Morten Vinje | Chairman | 0 companies |